Reed's, Inc. (NASDAQ: REED), maker of the top-selling sodas in natural food stores nationwide, announced today that it will be exhibiting at the Chemotherapy Foundation Symposium XXVII New Perspectives in Oncology Practice Seminar, Saturday November 14th, at the Marriott Marquis in New York, NY.
Mr. Neal Cohane, Senior VP of Marketing and Sales for Reed's, Inc. will be attending the event, staffing a booth where he will be distributing samples of Reed's Ginger Brews and Ginger Candy, and product literature discussing the benefits of ginger for chemotherapy related nausea. "This event will attract a diverse cross-section of Oncology professionals, including Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers, Pharmacists and other non-physician members of the oncology clinical care team. These are 'front line' professionals who often counsel their patients more closely than even the physicians themselves," stated Mr. Cohane.
Reed's attended the American Society of Clinical Oncology (ASCO) 2009 Annual Meeting in Orlando, Florida earlier this year. At that time, Reed's reported on a recently released study, funded by the National Cancer Institute, which found that ginger can successfully treat post-chemo nausea in cancer patients. Some of the findings were:
-- Up to 70% of patients become nauseated after chemo, according to the study of 644 people
-- According to the study's author, "Although drugs... can prevent vomiting, they don't always relieve nausea"
-- Ginger reduced patients' nausea levels by half, according to the study
-- The most effective doses were 1 gram and 0.5 gram a day, which are equal to half a teaspoon or one-quarter of a teaspoon of ground ginger, according to the study
-- Reed's Ginger Brews contain between 8 and 26 grams of ginger per serving
-- Reed's is the ONLY commercial soft drink manufacturer using fresh, whole ginger in its products
-- Significantly, ginger caused no side effects, according to the study